Ohio State Navbar


Tanios Bekaii-Saab, MD

Current OSU Appointments

  • Associate Professor, Internal Medicine, College of Medicine
  • Associate Professor, Pharmacology, College of Pharmacy
  • Section Chief, Gastrointestinal Oncology, James Cancer Hospital and Solove Research Institute
  • Leader, Disease Specific Research Group for Gastrointestinal Oncology, OSU Comprehensive Cancer Center

Education and Training

  • Bachelor of Science, McGill University
  • M.D., American University of Beiruit
  • Internal Medicine Residency, Indiana University Medical Center
  • Hematology and Oncology Fellowship, Tufts-New England Medical Center
  • Clinical Pharmacology and Experimental Therapeutics Fellowship, Tufts-New England Medical Center
Dr. Bekaii-Saab is one of America’s Best Doctors. Additionally, he has been listed in U.S. News and World Report’s Top Doctors for multiple consecutive years. His research interests include experimental therapeutics/translational research focused on molecularly-targeted and immune-mediated therapies in gastrointestinal (GI) cancers, and more specifically pancreas and biliary cancers. He is the principal investigator on numerous clinical trials, including studies supported through research grants from the National Cancer Institute (NCI) and the National Comprehensive Cancer Network (NCCN). He is also the recipient of numerous research grants from various industry partners. Dr. Bekaii-Saab is the recipient of the prestigious NCI clinical investigator team leadership award and the ASCO leadership program development award.